UNIGE document Scientific Article
previous document  unige:89078  next document
add to browser collection
Title

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy
Authors
Blondon, Marc
Wiggins, K L
Harrington, L B
Psaty, B M
Smith, N L
Published in Journal of Thrombosis and Haemostasis. 2013, vol. 11, no. 8, p. 1617-1619
Keywords ABO Blood-Group System/metabolism — Administration, Oral — Aged — Alleles — Case-Control Studies — Cytochrome P-450 CYP3A/metabolism — Female — Gene Frequency — Genetic Variation — Hormones/administration & dosage — Humans — Middle Aged — NF-E2-Related Factor 2/metabolism — Polymorphism, Single Nucleotide — Postmenopause — Pulmonary Embolism/blood — Regression Analysis — Risk Factors — Venous Thrombosis/blood — Washington
Identifiers
PMID: 23734777
Full text
Article (Published version) (76 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research group La maladie thromboembolique veineuse (808)
Citation
(ISO format) 		BLONDON, Marc et al. Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy. In: Journal of Thrombosis and Haemostasis, 2013, vol. 11, n° 8, p. 1617-1619. https://archive-ouverte.unige.ch/unige:89078

69 hits

0 download

Contact an author

Update request

Update

Deposited on : 2016-11-18

Export document
Format :
Citation style :